Open company graph database — free web & API
Login

CTD Co., Ltd.

株式会社CTD
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
4
§01

Basic information

BASIC
Head office
4F, Hatchobori MF Building, 1-2-9 Irifune, Chuo-ku, Tokyo 104-0042
Chief executive
Fumiaki Kobayashi
Capital
8,000,000
Employees (non-consolidated)
Employees (consolidated)
Start date
2010-02-22
End date
§02

Websites

2 DOMAINS
§03

Business

2
Consulting on clinical development and clinical trialsPlanning, operation, and management of clinical trials
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
ARTham Therapeutics Inc.
JMDC Inc.
JMDCグループ
Kousan Shinkin Bank
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

4 EVENTS

Member of the 2006 Committee for the Formulation of the Next Clinical Trial Activation PlanSources

Member of the 2007 Expert Working Group on Improving GCP Operations (including the Handling of Essential Documents)Sources

Member of the 2009 Committee on the Midterm Review of the New Five-Year Plan for Clinical Trial ActivationSources

Member of the Clinical Research and Clinical Trial Activation Working Group of the 2012 Study Group on Clinical Research and Clinical Trial ActivationSources

§07

News

8 ARTICLES

Customer Harassment Response Policy (Enactment)Sources

CTD Inc. has established a policy to address customer harassment, emphasizing the protection of employees' safety and health in order to maintain good relationships with business partners. The policy defines harassment as conduct by business partners that exceeds what is socially acceptable in the course of business, and provides examples such as unreasonable demands and physical or mental attacks.

To All Those Engaged in Job Search Activities (Establishment)Sources

CTD Inc. has established rules for interviews and selection processes to prevent sexual harassment in recruitment activities. Interviews are conducted from 9:00 to 17:00 in the company's conference rooms with multiple people present, and communication is limited to email only. A consultation desk has been set up, and it is guaranteed that the content of consultations will not affect the selection process.

Warning: Beware of Impersonation Emails Using Our Company NameSources

We have received reports of emails claiming to be from one of our employees and urging recipients to create a LINE group. The sender’s email address is clearly suspicious, and the message is not from our company. Even if an email comes from an address you recognize, delete it if its contents seem suspicious.

CTD Exhibits Booth at the 25th CRC ConferenceSources

CTD Inc., as a subsidiary of the JMDC Group, exhibited a booth at the 25th CRC Conference, which discusses the future of clinical trials. The conference was held at Omiya Sonic City from September 14 to 15, 2025, and CTD exhibited jointly with Pharma Inc. and Imepro Inc.

CTD Exhibits at the 46th Annual Meeting of the Japanese Society of Clinical Pharmacology with the JMDC GroupSources

CTD Co., Ltd. exhibited at the 46th Annual Meeting of the Japanese Society of Clinical Pharmacology together with Pharma and Aimepro, members of the JMDC Group. The meeting was held at Station Conference Tokyo from December 5 to 6, 2025.

Speaking at a Webinar on Physician-Initiated Clinical TrialsSources

Fumiaki Kobayashi, President and Representative Director of CTD Co., Ltd., spoke at a free online seminar hosted by Mediford Corporation on “Why Physician-Initiated Clinical Trials Now?—Their Track Record and Significance, and How They Differ from Company-Sponsored Trials.” At the seminar, Takahiro Sato of Mediford Corporation also introduced central laboratory services that support clinical trials. The seminar was held on Thursday, August 28, 2025, from 3:00 to 4:00 p.m.

Four JMDC Group Companies Exhibit at the Japanese Society of Clinical PharmacologySources

Four JMDC Group companies—Pharma Co., Ltd., CTD Co., Ltd., Aimepro Co., Ltd., and Real World Data Co., Ltd.—jointly exhibited at the 45th Annual Meeting of the Japanese Society of Clinical Pharmacology, held at Omiya Sonic City.

Joint Presentation at the Japanese Society of Clinical PharmacologySources

At the 45th Annual Meeting of the Japanese Society of Clinical Pharmacology, we gave a joint presentation on “patient involvement” and “peer support” in clinical trials for rare diseases. The presentation took place on Saturday, December 14, in General Abstracts (Poster) 13, “Clinical Trials 1.”

§08

Public records

GOV
National Tax Agency basic information7010001130739
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社CTD
Trade name (kana)
シーティディ
Name in English
Corporation type
301
Address
〒104-0042 東京都中央区入船1丁目2番9号
Postal code
1040042
Prefecture code
13
City code
102
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2023-05-16
Change date
2021-08-11
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
1
Trade name image ID
Address image ID
Sequence number
2169185
METI gBizINFO7010001130739
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
7010001130739
Trade name
株式会社CTD
Trade name (kana)
シーティディ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都中央区入船1丁目2番9号
Postal code
1040042
Prefecture
東京都
Prefecture code
13
City or district
中央区
City code
102
Street address
入船1丁目2番9号
Organisation type
301
Processing type
12
Correction type
1
Status
Representative
代表取締役 小林 史明
Capital
Employees
14
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
R:サービス業(他に分類されないもの)
Date established
2010-02-22
Unified government qualification - grade
||C|
Unified government qualification - business items
303|304
Update date
2023-05-16
Key information
7010001130739
§09

Sources & updates

SOURCES
↑